Nihon Kohden Corporation
Nihon Kohden Corporation (NHNKF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
nhnkf · pe ratio · data through Mar 31, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Nihon Kohden Corporation (NHNKF) measures how much investors pay for each dollar of the company's trailing earnings. NHNKF's current PE ratio of 15.63x is calculated by dividing its stock price of $10.90 by its TTM earnings per share of $89.44. −2.7% discount vs 5Y avg 16.1x
Source: FMP · /ratios-ttm · /analyst-estimates · 2026-03-31
PE Ratio History
2007 – 2026 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%9.7x
MedianQ3 · 75%26.6x
Max
At 15.63x, NHNKF's current P/E is higher than in 85% of its annual fiscal year readings over the past 20 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Nihon Kohden CorporationYou NHNKF | $1.7B | 15.63x | -47.4% | $89.44 |
 Alfresa Holdings Corporation ARHCF | $2.2B | 8.15x | -72.5% | $231.09 |
 Biotage AB (publ) BITGF | $1.2B | 46.23x | +55.7% | $3.55 |
 CompuGroup Medical SE & Co. KGaA CMPUY | $1.2B | 33.34x | +12.3% | $0.67 |
 CompuGroup Medical SE & Co. KGaA CMPVF | $1.7B | 52.49x | +76.8% | $0.55 |
 Drägerwerk AG & Co. KGaA DGWPF | $1.4B | 8.23x | -72.3% | $7.44 |
 Drägerwerk AG & Co. KGaA DWRKF | $1.8B | N/A | — | — |
Industry Average 5 peers with valid PE | — | 29.69x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2026-03-31Latest FY2026 | 26.63x | $89.82 | +0.0% | |
2025-03-31 FY2025 | 26.62x | $84.88 | +51.2% | |
2024-03-31 FY2024 | 17.60x | $101.23 | +150.3% | |
2023-03-31 FY2023 | 7.03x | $203.28 | +190.6% | |
2022-03-31 FY2022 | 2.42x | $276.50 | -66.8% | |
2021-03-31 FY2021 | 7.29x | $214.21 | -36.7% | |
2020-03-31 FY2020 | 11.51x | $115.72 | +9.6% | |
2019-03-31 FY2019 | 10.50x | $131.42 | -14.8% | |
2018-03-31 FY2018 | 12.31x | $106.92 | -4.7% | |
2017-03-31 FY2017 | 12.92x | $106.81 | +15.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Nihon Kohden Corporation (NHNKF) measures how much investors pay for each dollar of the company's trailing earnings. NHNKF's current PE ratio of 15.63x is calculated by dividing its stock price of $10.90 by its TTM earnings per share of $89.44.
Frequently asked questions
NHNKF pe ratio · 6 questionsNHNKF's current PE ratio is 15.63x as of 2026-06-09, based on a stock price of $10.90 and TTM EPS of $89.44. Data sourced from Financial Modeling Prep via NHNKF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Nihon Kohden Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09